| Literature DB >> 36187003 |
Weimei Yang1, Xifei He1, Zhaozhao Wang1, Lijuan Lu1, Ge Zhou1, Jie Cheng1, Xinying Hao2.
Abstract
Aims: This study intends to explore the research focus and trends of fulminant myocarditis (FM) to have a better understanding of the topic. Materials and methods: The data were downloaded from the Web of Science (WoS) database using the topic (TS) advanced search strategy. Many instruments were used to extract, analyze, and visualize the data, such as Microsoft Excel, HistCite Pro, GunnMap, BibExcel, and VOSviewer.Entities:
Keywords: bibliometric analysis; citation network; fulminant myocarditis (FM); research focus; theme trends
Year: 2022 PMID: 36187003 PMCID: PMC9515361 DOI: 10.3389/fcvm.2022.935073
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
FIGURE 1Flowchart of the methodology.
FIGURE 2Growth trend of the Web of Science documents “fulminant myocarditis” research over the last 30 years.
FIGURE 3(A) Global geographic distribution of the total number of documents by country and (B) the top 10 prolific countries based on the number of publications related to “fulminant myocarditis” research.
FIGURE 4Network visualization map of country co-authorships. Thicker lines indicate stronger collaborations. Countries represented with larger circle size or font size had relatively more publications.
Quantitative measurements of journals publishing documents concerning “fulminant myocarditis” research.
| Rank | Source title | JIF2020 (R) | TA (%) | TGCS | GCSA | JC |
| 1 | Circulation Journal | 3.0 | 22 (3.0%) | 572 | 26.0 | Japan |
| 2 | Journal of Heart and Lung Transplantation | 10.2 | 19 (2.6%) | 499 | 26.3 | United States |
| 3 | Annals of Thoracic Surgery | 4.3 | 17 (2.3%) | 568 | 33.4 | United States |
| 4 | Esc Heart Failure | 4.4 | 17 (2.3%) | 47 | 2.8 | England |
| 5 | Pediatric Cardiology | 1.7 | 14 (1.9%) | 260 | 18.6 | United States |
| 6 | Internal Medicine | 1.3 | 13 (1.8%) | 76 | 5.8 | Japan |
| 7 | Journal of Artificial Organs | 1.7 | 13 (1.8%) | 74 | 5.7 | Japan |
| 8 | ASAIO Journal | 2.9 | 11 (1.5%) | 187 | 17.0 | United States |
| 9 | Japanese Circulation Journal-English Edition | 1.4 | 11 (1.5%) | 126 | 11.5 | Australia |
| 10 | American Journal of Emergency Medicine | 2.5 | 10 (1.4%) | 37 | 3.7 | United States |
| 11 | Artificial Organs | 3.1 | 10 (1.4%) | 153 | 15.3 | United States |
| 12 | European Heart Journal-Case Reports | – | 10 (1.4%) | 26 | 2.6 | England |
| 13 | Herz | 1.4 | 10 (1.4%) | 161 | 16.1 | German |
| 14 | Circulation | 29.7 | 8 (1.1%) | 577 | 72.1 | United States |
| 15 | International Heart Journal | 1.9 | 8 (1.1%) | 54 | 6.8 | Japan |
| 16 | International Journal of Cardiology | 4.2 | 8 (1.1%) | 95 | 11.9 | Ireland |
| 17 | Medicine | 1.9 | 8 (1.1%) | 10 | 1.3 | United States |
| 18 | Pediatric Critical Care Medicine | 3.6 | 8 (1.1%) | 42 | 5.3 | United States |
| 19 | Frontiers in Cardiovascular Medicine | 6.1 | 7 (1.0%) | 1 | 0.1 | Switzerland |
| 20 | Journal of the American College of Cardiology | 24.1 | 7 (1.0%) | 1,075 | 153.6 | United States |
JIF, journal impact factor; TA, total articles; TGCS, total global citation score; GCSA, global citation score per article; JC, journal country.
Quantitative measurements of institutions publishing articles concerning “fulminant myocarditis” research.
| Rank | Institution | Country | TA | TA (%) | TGCS | GCSA |
| 1 | Columbia University | United States | 15 | 2.1 | 296 | 19.7 |
| 2 | Huazhong University Science and Technology | China | 13 | 1.8 | 69 | 5.3 |
| 3 | National Cerebral and Cardiovascular Center | Japan | 12 | 1.7 | 136 | 11.3 |
| 4 | Ospedale Niguarda Ca’ Granda | Italy | 12 | 1.7 | 516 | 43.0 |
| 5 | Harvard Medical School | United States | 11 | 1.5 | 1574 | 143.1 |
| 6 | Massachusetts General Hospital | United States | 11 | 1.5 | 2196 | 199.6 |
| 7 | Mayo Clinic | United States | 11 | 1.5 | 362 | 32.9 |
| 8 | Fujita Health University | Japan | 10 | 1.4 | 242 | 24.2 |
| 9 | University Texas MD Anderson Cancer Center | United States | 10 | 1.4 | 1518 | 151.8 |
| 10 | Vanderbilt University | United States | 10 | 1.4 | 1851 | 185.1 |
| 11 | Chang Gung University | China Taiwan | 9 | 1.2 | 145 | 16.1 |
| 12 | Cleveland Clinic | United States | 9 | 1.2 | 228 | 25.3 |
| 13 | Harvard University | United States | 9 | 1.2 | 374 | 41.6 |
| 14 | Kitasato University | Japan | 9 | 1.2 | 344 | 38.2 |
| 15 | Nagoya University | Japan | 9 | 1.2 | 110 | 12.2 |
| 16 | University of Pennsylvania | United States | 9 | 1.2 | 460 | 51.1 |
| 17 | Charite – University Medicine Berlin | Germany | 8 | 1.1 | 161 | 20.1 |
| 18 | Johns Hopkins University | United States | 8 | 1.1 | 2279 | 284.9 |
| 19 | Mie University | Japan | 8 | 1.1 | 155 | 19.4 |
| 20 | Kyoto University | Japan | 7 | 1.0 | 298 | 42.6 |
TA, total articles; TGCS, total global citation score; GCSA, global citation score per article.
FIGURE 5Co-occurrence network of the terms with occurrences of 5 or more extracted. The larger circle size or font size indicates a higher occurrence.
FIGURE 6The top five representative keywords of each cluster.
FIGURE 7The top 10 research categories ranked by count.
Top 20 cited articles on “fulminant myocarditis” research from the inception of the searched databases to 2022.
| Rank | Article | Author(s) | Journal | TC | TC/Y |
| 1 | Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline ( | Brahmer et al. | Journal of Clinical Oncology | 1,327 | 265.4 |
| 2 | Fulminant myocarditis with combination immune checkpoint blockade ( | Johnson et al. | New England Journal of Medicine | 926 | 132.29 |
| 3 | Long-term outcome of fulminant myocarditis as compared with acute (non-fulminant) myocarditis ( | McCarthy et al. | New England Journal of Medicine | 502 | 21.83 |
| 4 | Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock ( | Combes et al. | Critical Care Medicine | 409 | 27.27 |
| 5 | Myocarditis in patients treated with immune checkpoint inhibitors ( | Mahmood et al. | Journal of The American College of Cardiology | 363 | 72.6 |
| 6 | Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study ( | Salem et al. | Lancet Oncology | 294 | 58.8 |
| 7 | Clinicopathological description of myocarditis ( | Lieberman et al. | Journal of The American College of Cardiology | 232 | 7.25 |
| 8 | First case of COVID-19 complicated with fulminant myocarditis: a case report and insights ( | Zeng et al. | Infection | 216 | 72 |
| 9 | Echocardiographic findings in fulminant and acute myocarditis ( | Felker et al. | Journal of The American College of Cardiology | 207 | 9 |
| 10 | Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program) ( | Beurtheret et al. | European Heart Journal | 173 | 17.3 |
| 11 | Mechanical circulatory support for the treatment of children with acute fulminant myocarditis ( | Duncan et al. | Journal of Thoracic and Cardiovascular Surgery | 158 | 7.18 |
| 12 | Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support ( | Mirabel et al. | Critical Care Medicine | 133 | 11.08 |
| 13 | Is there an association between COVID-19 mortality and the renin-angiotensin system? A call for epidemiologic investigations ( | Hanff. et al. | Clinical Infectious Diseases | 129 | 43 |
| 14 | Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation ( | Asaumi et al. | European Heart Journal | 123 | 6.83 |
| 15 | Recognition and initial management of fulminant myocarditis: A scientific statement from the American Heart Association ( | Kociol et al. | Circulation | 117 | 39 |
| 16 | An outbreak of enterovirus 71 infection in Taiwan 1998: A comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis ( | Yan et al. | Journal of Clinical Virology | 115 | 5 |
| 17 | A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls ( | Ronaldson et al. | Australian and New Zealand Journal of Psychiatry | 110 | 9.17 |
| 18 | Inflammatory cardiomyopathic syndromes ( | Trachtenberg et al. | Circulation Research | 105 | 17.5 |
| 19 | Venoarterial ECMO for adults: JACC scientific expert panel ( | Guglin et al. | Journal of The American College of Cardiology | 104 | 26 |
| 20 | Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: What mechanical support should be considered first? ( | Chen et al. | Journal of Heart And Lung Transplantation | 99 | 5.5 |
TC, total citation; TC/Y, average citations per year, which is the TC divided by the year.
Top 20 contributing authors in terms of articles.
| Rank | Author | Affiliation | TA | TA (%) | TGCS | GCSA |
| 1 | Klingel K | University Hospital Tubingen | 12 | 1.7 | 327 | 27.3 |
| 2 | Ammirati E | Ospedale Niguarda Ca’ Granda | 11 | 1.5 | 374 | 34.0 |
| 3 | Frigerio M | Ospedale Niguarda Ca’ Granda | 11 | 1.5 | 359 | 32.6 |
| 4 | Izumi T | Kitasato University | 10 | 1.4 | 414 | 41.4 |
| 5 | Fujita T | National Cerebral and Cardiovascular Center | 9 | 1.2 | 43 | 4.8 |
| 6 | Wang Y | Shandong University | 9 | 1.2 | 264 | 29.3 |
| 7 | Cipriani M | Ospedale Niguarda Ca’ Granda | 8 | 1.1 | 298 | 37.3 |
| 8 | Cooper LT | Mayo Clinic | 8 | 1.1 | 299 | 37.4 |
| 9 | Kobayashi J | National Cerebral and Cardiovascular Center | 8 | 1.1 | 42 | 5.3 |
| 10 | Minami K | National Cerebral and Cardiovascular Center | 8 | 1.1 | 126 | 15.8 |
| 11 | Yanase M | National Cerebral and Cardiovascular Center | 8 | 1.1 | 41 | 5.1 |
| 12 | Combes A | Hopital La Pitie Salpetriere | 7 | 1.0 | 842 | 120.3 |
| 13 | Fukushima N | National Cerebral and Cardiovascular Center | 7 | 1.0 | 22 | 3.1 |
| 14 | Ito M | Mie University | 7 | 1.0 | 67 | 9.6 |
| 15 | Kato S | University Ryukyus | 7 | 1.0 | 118 | 16.9 |
| 16 | Moslehi JJ | Vanderbilt University | 7 | 1.0 | 1844 | 263.4 |
| 17 | Seguchi O | National Cerebral and Cardiovascular Center | 7 | 1.0 | 37 | 5.3 |
| 18 | Wang DW | Huazhong University Science and Technology | 7 | 1.0 | 39 | 5.6 |
| 19 | Wang J | Shandong University | 7 | 1.0 | 48 | 6.9 |
| 20 | Asaumi Y | National Cerebral and Cardiovascular Center | 6 | 0.8 | 160 | 26.7 |
TA, total articles; TGCS, total global citation score; GCSA, global citation score per article, which is the TGCS divided by the TA.
FIGURE 8Author co-citation network analysis in the field of “fulminant myocarditis” research. (A-1,A-2) are partially enlarged views of (A).